FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis

FDA requires a Boxed Warning about serious mental health side effects for the asthma& allergy drug Singulair (montelukast). Only take montelukast for hay fever if other medicines do not work or cannot be tolerated.

Source: FDA Center for Drug Evaluation and Research - What's New - March 4, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news